SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-201941
Filing Date
2013-05-06
Accepted
2013-05-06 17:19:32
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d514747d10q.htm 10-Q 740654
2 EX-31.1 d514747dex311.htm EX-31.1 9204
3 EX-31.2 d514747dex312.htm EX-31.2 9299
4 EX-32.1 d514747dex321.htm EX-32.1 4589
  Complete submission text file 0001193125-13-201941.txt   5289787

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itmn-20130331.xml EX-101.INS 745855
6 XBRL TAXONOMY EXTENSION SCHEMA itmn-20130331.xsd EX-101.SCH 45857
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itmn-20130331_cal.xml EX-101.CAL 67822
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itmn-20130331_def.xml EX-101.DEF 279400
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itmn-20130331_lab.xml EX-101.LAB 373726
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itmn-20130331_pre.xml EX-101.PRE 324350
Mailing Address 3280 BAYSHORE BLVD BRISBANE CA 94005
Business Address 3280 BAYSHORE BLVD BRISBANE CA 94005 415 466 2200
INTERMUNE INC (Filer) CIK: 0001087432 (see all company filings)

IRS No.: 943296648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29801 | Film No.: 13817100
SIC: 2834 Pharmaceutical Preparations